1

Kantar Health covers the whole scope of Real World Research and Value

Real world research and

value

Treatment patterns

Patient outcomes

Health economics

Risk managementEpidemiology

Unmet needs

Using

Outcomes research(SLR, MTC, meta-analysis)

Real life studies, NIS, Observational studies, PRO

Primary data Adhoc protocols (OMT®)

Syndicated data (NHWS®, EpiDatabase®, CancerMPact®, PainMPact®)

• Treatment algorithms• Patient pathways• Duration of

treatment/dosage• Drug utilization

• Identification of gaps in disease management

• For ALL stakeholders: physicians, patients, payers, pharmacists, caregivers

• Size target population

• Patient profiles• Registries

• Bol/QoL• PRO development

and validation• Patient preference• Patient adherence• Patient satisfaction

• Resource utilization (direct and indirect costs)

• Economic modelling (in collaboration with WG)

• PASS• Pharmaco-

epidemiology• Large cohort studies• Registries

Claims and EHR datasets (US, Germany, Israel, and Brazil)